Home / Blog / What Does Tesamorelin Do? Mechanism and Research

What Does Tesamorelin Do? Mechanism and Research

Research reference · Updated September 2026 · ~6 min read

Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH). To understand what it does, it helps to follow the hormone chain it acts on. This overview explains the mechanism in plain terms. Research information only.

The GHRH pathway

Your hypothalamus naturally produces GHRH, which signals the pituitary gland to release growth hormone. Growth hormone then travels to the liver and other tissues, where it prompts the production of IGF-1. Tesamorelin mimics GHRH, so it acts at the very top of this chain, encouraging the pituitary to release growth hormone in a natural pulsing pattern.

Why the stabilization matters

Native GHRH breaks down within minutes. Tesamorelin is modified to resist that breakdown, giving it a longer working window. This is what separates it from unstable GHRH and makes it practical for once-daily dosing, as covered in the tesamorelin dosage guide.

Approved use context: tesamorelin is the rare peptide in this class with a formal clinical approval, specifically for reducing excess visceral abdominal fat in a defined patient group. That clinical history gives it more human data than most research peptides.

What it is studied for

How it differs from a secretagogue like ipamorelin

Tesamorelin works on the GHRH receptor, while ipamorelin works on the ghrelin receptor. They reach the same goal, more growth hormone, by different doors. The full comparison is in tesamorelin vs ipamorelin, and related peptides are in the protocol library.

See tesamorelin dosing

Tesamorelin Dosage Guide →

Related research guides

⚠️ RESEARCH USE ONLY: This content is for educational and research purposes only. Peptides discussed are not approved for human consumption. Nothing here is medical advice. Consult qualified professionals.